TrialJAMA internal medicine2021

Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial.

Lin-Ling Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.